Dear Readers, Pharma Industrial India Magazine is happy to share its latest work i.e January-February 2024 issue with you. The issue brings standalone thought leadership from: Puunam G Kaushik, Deputy Managing Director and Chief Corporate Affairs, Meteoric Biopharmaceuticals Pvt. Ltd. ; Jashan Bhumkar, Director, Soujanya Lifesciences The issue also offers insight into various sectors through thought pieces from various industry pioneers and accelerators: Abhishek Batni, Consultant; Prashant VV, Consultant, Avalon Consulting; Sehgal Madhur, Head of Climate Solutions, Danfoss India Region; Do read the complete magazine here: https://lnkd.in/dwUQfr6q We hope you enjoy our work!!! #biotech #india #healthcare #manufacturing #drugsanddevelopment #equipment #treatment #biotechnology #globalpharma #pharmaceuticals #PharmaIndustrialIndia
Pharma Industrial India
Media Production
Pune, Maharashtra 5,395 followers
PROFESSIONAL MAGAZINE FOR PHARMA INDUSTRY SUPPLIERS AND LAB TECHNOLOGY
About us
PHARMA INDUSTRIAL INDIA is published by Omnimedia Publications India Pvt. Ltd. A 100% subsidiary of the European Omnimedia Group an International Publishing Company with leading technical magazines in the Energy, Construction, Tourism, Pharma and Life Sciences Industries, headquartered in Madrid, Spain. International Magazine for Pharmaceutical Industry Suppliers and Lab Technology. The Indian Pharma Industry expands rapidly and is already one of the largest pharmaceutical producers worldwide. This huge market requires technical equipment and services to compete in any phase of the pharmaceutical development, from the research stage to the final product.
- Website
-
http://www.pharmaindustrial-india.com/
External link for Pharma Industrial India
- Industry
- Media Production
- Company size
- 51-200 employees
- Headquarters
- Pune, Maharashtra
- Founded
- 2009
- Specialties
- Pharma Industry Magazine and Pharma Industrial India
Updates
-
Mabwell has announced that its novel Nectin-4 targeting ADC has been approved by the NMPA to enter Phase II clinical trial as monotherapy or in combination with a PD-1 inhibitor for the treatment of triple-negative breast cancer (TNBC). #healthcare #PharmaIndustrialIndia
-
Modicus Prime has received USD 3.5 million in series seed #funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms. #healthcare #PharmaIndustrialIndia
Modicus Prime Secures USD 3.5 Million in Series Seed Funding - Global Pharma
pharmaindustrial-india.com
-
Merck has started the commercial #production of its first GMP (Good Manufacturing Practices) compliant #manufacturing line for cell culture media (CCM) in China. #healthcare #PharmaIndustrialIndia
Merck Begins Commercial Production of GMP-Compliant Manufacturing Line for CCM in China - Manufacturing
pharmaindustrial-india.com
-
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A #financing round. Guofeng Cheng #healthcare #PharmaIndustrialIndia
AusperBio Receives USD 37 Million in Series A Financing Round - Global Pharma
pharmaindustrial-india.com
-
Alembic Pharmaceuticals Limited has secured tentative approval from the US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) Selexipag for Injection, 1,800 mcg/vial. #healthcare #PharmaIndustrialIndia
Alembic Pharma Gets USFDA Tentative Approval for Selexipag for Injection - Global Pharma
pharmaindustrial-india.com
-
Moderna, Inc. has signed a #jointagreement with Mitsubishi Tanabe Pharma America regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax. Kazumasa N. Akihiro Tsujimura #healthcare #PharmaIndustrialIndia
Moderna and Mitsubishi Tanabe Pharma to Promote mRNA Respiratory Vaccine in Japan - Global Pharma
pharmaindustrial-india.com
-
Nona Biosciences has entered into a collaboration #agreement with Alaya.bio to precisely target and reprogram cells in situ and thus to significantly simplify the way CAR-T cell therapies in particular are being developed, manufactured and administered. Jingsong Wang Renaud VAILLANT #healthcare #PharmaIndustrialIndia
Nona Biosciences Signs Partnership Deal with Alaya.bio to Advance CAR-T Cell Therapy - Drug Discovery & Development
pharmaindustrial-india.com
-
Dr. Reddy's Russia arm, part of the global pharmaceutical company Dr. Reddy's Laboratories, has introduced Muslaxin (INN Ibuprofen 400 mg + Chlorzoxazone 500 mg), the first combination drug of NSAID and muscle relaxant that does not have generics in the Russian Federation. #healthcare #PharmaIndustrialIndia
Dr. Reddy's Laboratories Launches Muslaxin in Russia - Drug Discovery & Development
pharmaindustrial-india.com
-
Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). Jasdave Chahal #healthcare #PharmaIndustrialIndia
BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza - Global Pharma
pharmaindustrial-india.com